Know Cancer

or
forgot password

Psychosocial Support for Cancer Patients


N/A
18 Years
N/A
Not Enrolling
Both
Cancer

Thank you

Trial Information

Psychosocial Support for Cancer Patients


Primary Objective:

- To establish the efficacy of a new and unique individual, brief intervention we call
"Dignity Psychotherapy" in enhancing a sense of meaning, purpose and overall well-being
for patients with advanced, end stage cancer.

Secondary Objectives:

- To compare the effectiveness of "Dignity Psychotherapy" with "Supportive Psychotherapy"
and "Standard Palliative Care" in bolstering the patients' sense of meaning, purpose,
generativity, and overall sense of dignity and quality of life, while lessening
hopelessness, sense of being a burden to others, and suffering.

- To explore the impact "Dignity Psychotherapy" has on the bereavement experience of
those family members/significant others taking part in this arm of the study protocol.

- To compare the bereavement experience of bereaved family members/significant others
whose loved ones took part in any one of the three study conditions.


Inclusion Criteria:



- The patient must be at least 18 years of age (because of the nature of "Dignity
Psychotherapy," which presumes a relatively advanced level of social and
psychological development).

- Have a terminal illness (Stage IV with a prognosis of less than 6 months, but
expected to live at least 7 to 10 days, i.e. the average length of the protocol)

- Must be able to identify a family member/significant other who agrees to participate
in the study (in the case of "Dignity Psychotherapy," this family member/significant
other will receive the generativity document)

- Be able to communicate with an English-speaking therapist (patients who are visually
impaired will be offered assistance with the consent forms and surveys)

- In the investigator's judgement, participant is cognitively able to provide valid,
informed consent.

Exclusion Criteria:

- Significant psychiatric disturbance sufficient to preclude participation in a
psychotherapeutic intervention (e.g. acute, severe psychiatric symptoms which would
require individual treatment and medication management rather than a psychotherapy
intervention).

- Active psychotic mental disorder (e.g. schizophrenia, acute mania), or marked
paranoid ideation. Patients who are on stable regimens of psychotropic medications
(e.g. antidepressants for clinical depression) or who are in concurrent individual or
group psychotherapy will not be excluded. This information regarding concurrent
psychiatric treatment will be collected and utilized as a co-variate in data
analysis.

- Presence of a cognitive disturbance (i.e. delirium or dementia) sufficient to
preclude participation in psychotherapy, and/or data collection.

- Physical limitations or illness severity sufficient to preclude participation in
psychotherapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To establish the efficacy of a new and unique individual, brief intervention called "Dignity Psychotherapy" in enhancing a sense of meaning, purpose and overall well-being for patients with advanced, end stage cancer

Outcome Time Frame:

7-10 days

Safety Issue:

No

Principal Investigator

William Breitbart, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

05-042

NCT ID:

NCT00133965

Start Date:

May 2005

Completion Date:

April 2011

Related Keywords:

  • Cancer
  • Advanced Cancer
  • Dignity Care
  • Supportive Care
  • Quality of Life
  • Psychotherapy
  • Palliative Care

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021